top of page

The Future of Medical Cannabis in Thailand: A Comprehensive Overview

In recent years, Thailand has marked its place on the map for its progressive stance on medical cannabis, a significant pivot from the country's historical stringent drug laws. As global attitudes toward marijuana shift, the nation is poised to emerge as a leader in the medical marijuana industry in Southeast Asia, largely influenced by traditional use and modern research that underscores its therapeutic potential. This paradigm shift presents both intriguing prospects and unique challenges in the realms of legislation, healthcare, and business as Thailand continues to navigate the complexities of cannabis reform.

The discourse on medical cannabis is gaining momentum, fueled by advancements in technology that streamline cultivation and distribution, along with a keen interest in the potential medical applications ranging from chronic pain management to sleep improvement. As the legal landscape of medical cannabis evolves, examining its future becomes crucial for stakeholders at all levels. The subsequent sections will delve into the intricacies of legal reforms, user experiences, and the transformative impact of technology on the industry as Thailand looks ahead to the future of medical cannabis.

The Legal Landscape of Medical Cannabis in Thailand

  • In 2018, Thailand became a pioneer in Southeast Asia by legalizing medical cannabis, with subsequent legislation such as the Narcotics Act of 2019 legitimizing its use for specific medical conditions [1][9][10].

  • The Ministry of Public Health has identified three categories of medical conditions eligible for cannabis treatment, and healthcare providers licensed in Thailand can prescribe approved cannabis products to patients [1].

  • The Government Pharmaceutical Organization has been tasked with overseeing the production and distribution of medical cannabis, with a goal set to produce 15,000 bottles of cannabis oil by the end of 2020 [1].

  • Regulations are stringent, mandating licenses for growers, distributors, and users, and establishing the Thai Food and Drug Administration's control over hospital and clinic usage [1][5].

  • Private sector cultivation for medical and research purposes is on the horizon, potentially spurring industry growth, yet the regulatory landscape remains unclear with political contention and market challenges like intellectual property and international trade restrictions [1][2][3].

  • Despite decriminalization for medical and limited private recreational use, public consumption and recreational cannabis remain illegal, with specific prohibitions for minors, pregnant and breastfeeding women, and public nuisance concerns [4][5].

  • Households can grow a limited number of plants upon registration, but public smoking carries hefty fines or jail time, and THC levels in food and drink must not exceed 0.2% [4][5].

  • The government's stance is to promote medical cannabis while curbing recreational use, as evidenced by the distribution of one million free cannabis plants to households and the push for tightened industry regulations [5][8].

  • A revised bill submitted in December 2023 aims to close loopholes, set cultivation guidelines, and introduce penalties, signaling a shift back to a health and economy focus for the cannabis sector [5][8].

Medical Applications and User Experiences

  • In Thailand, a study at Siriraj Hospital revealed that 15% of chronic cancer pain patients and 3.1% of chronic non-cancer pain patients actively used medical cannabis. The preferred method of consumption was oil extract administered sublingually, primarily for pain control [11].

  • While no serious side effects were reported, users did experience some common side effects, including dry oral mucosa, drowsiness, and headaches. Interestingly, the majority of cannabis was obtained from friends rather than official sources [11].

  • Active cannabis users among cancer patients showed higher scores on the Edmonton Symptom Assessment System (ESAS) for lack of appetite, anxiety, and on the Brief Pain Inventory (BPI) for enjoyment of life. Conversely, in non-cancer pain patients, only the mood subscale BPI was lower among active users, suggesting a variance in cannabis's impact on different conditions [11].

  • Another study using respondent-driven sampling (RDS) highlighted that oral crude oil extract was the most commonly used form of medical cannabis, with treatments aimed at cancers, neuropsychiatric symptoms, and musculoskeletal pains. Despite the legalization, most of this cannabis came from illegal sources like underground traders and clandestine growers, raising concerns about product quality [12].

  • The perception among users is that cannabis can effectively treat a range of conditions from cancers to chronic pains and insomnia, with fewer acknowledging the potential for adverse effects like palpitations or memory impairment. This indicates a strong belief in the medicinal benefits of cannabis, aligned with support for policies permitting its medical use and legal sale [9][12].

  • A cross-sectional study of non-palliative care patients with neuropathic pain showed that nearly half experienced a significant reduction in pain after using medical cannabis, with notable improvements in sleep quality. However, common side effects like dizziness and palpitations led to a small percentage discontinuing use [13].

  • Research involving 485 medical cannabis consumers in Thailand found a consensus on the economic benefits of the cannabis industry, with 80% agreeing that it would positively impact the economy. Yet, despite the legal status, most consumers still relied on illegal sources, which poses risks due to the uncertain cannabinoid content and production standards [9].

  • The prevalence of cannabis intoxication and other adverse events has been increasing, signaling a widespread consumption of low-quality products and highlighting the need for better regulation and quality control in the market [9].

Challenges and Opportunities

  • The Thai cannabis market, though nascent, holds significant growth potential, with technology in cultivation and distribution poised to drive this expansion. However, the COVID-19 pandemic posed a setback, causing supply chain disruptions and a market decline from 2019 to 2020, particularly affecting CBD research [14][15].

  • Despite these challenges, the market is on an upward trajectory, with projections estimating its value to soar to US$ 1,408.0 Million by 2028. This growth could yield substantial economic benefits for Thailand, including job creation, increased tourism, and export opportunities [7][1].

  • The medical cannabis industry's potential extends to healthcare, with the promise of better outcomes for patients suffering from conditions like pain, epilepsy, and PTSD. Moreover, increased access to medical cannabis could aid patients who struggle with the costs or availability of conventional treatments [1].

  • On the regulatory front, Thailand faces hurdles with stringent rules, such as limited production licenses and restrictions on product types, which may impede market and research development [12].

  • Public perception presents another challenge; the stigma surrounding cannabis use could hinder the acceptance and support for medical cannabis initiatives [12].

  • Research scarcity on cannabis's medicinal benefits complicates informed decision-making for policymakers and healthcare providers, and the limited number of licensed producers could restrict patient access to high-quality medical cannabis [12].

  • Over 700 medical cannabis clinics across the nation could improve legal access, reduce illicit trade, and enhance product quality, provided the government ensures a consistent supply from certified sources [9].

  • The evolving legal landscape, including the recent law revisions, might attract or deter foreign investment, making it crucial for international businesses to monitor the Thai government's regulatory approach closely [8].

  • The legalization of medical marijuana and hemp industry growth opens new business avenues, but the government must address the concerns of businesses affected by legal changes [16].

  • Targeted strategies, such as allowing cannabis sales to specific tourist groups in cities like Bangkok and Chiang Mai, could bolster both the tourism sector and local businesses, creating a win-win scenario for the economy [16].

The Role of Technology in Cultivation and Distribution

  • The integration of IoT and smart agriculture is revolutionizing the way cannabis is cultivated in Thailand. These technologies allow for precise monitoring and management of the growing environment, ensuring that conditions such as temperature, humidity, and soil moisture are optimal for plant health and cannabinoid production [17].

  • IoT sensors collect real-time data, which is then used to automate climate control systems, irrigation, and even nutrient delivery, leading to more predictable harvests and higher quality yields [17].

  • Advanced LED lighting systems are being employed to cater specifically to the light spectrum requirements of the cannabis plant. This not only boosts growth rates but also enhances the potency of the final product, which is crucial for medical applications where consistency and quality are paramount [17].

  • By adjusting light wavelengths, growers can manipulate plant behaviors such as flowering time and terpene profiles, tailoring their crops to meet specific medical needs [17].

  • Data analytics and big data play a crucial role in refining cultivation strategies. By analyzing large datasets, growers can make informed decisions that optimize the growth process and ensure their product offerings align with current market demands [17].

  • This data-driven approach helps identify patterns and trends that can lead to improvements in cultivation techniques, pest management, and even strain selection [17].

  • Bloom Thailand is at the forefront of introducing innovative cloning technology to underprivileged communities in Bangkok. This initiative not only provides education but also resources that enable these communities to cultivate cannabis more efficiently, making better use of limited space and resources [18].

  • The cloning technique ensures the production of genetically identical plants, which leads to uniformity in the crop and simplifies the cultivation process for novice growers [18].

  • Companies like Eternal Energy Plc, Cannabiz Way Co Ltd, AgrowLab Co Ltd, and AgrowPlus Co Ltd are investing in precision farming technologies. These technologies include greenhouse planting systems, AI, and IoT, which are essential for growing medical-grade and food-grade hemp and marijuana [19].

  • Greenhouse technology creates a controlled environment that can be manipulated to suit the specific needs of cannabis plants, protecting them from adverse weather and pests [19].

  • The use of AI and IoT in these greenhouses allows for the automation of tasks such as watering and feeding, leading to more efficient resource use and reduced labor costs [19].

Looking Ahead: The Future of Medical Cannabis in Thailand

  • Thailand's medical cannabis market is on a trajectory of robust growth, with projections indicating a rise in revenue from US$1,220.00m in 2024 to US$2,007.00m by 2028, at a CAGR of 13.25% [20].

  • This growth is further underscored by expectations that the market will expand to USD 132.05 billion by 2031, driven by a significant CAGR of 25.16% from 2024 to 2031 [3].

  • Concurrently, the medical cannabis industry in Thailand is forecasted to increase its revenue to US$9.92 million in 2024, maintaining a steady growth rate of 11.40% leading up to 2028, resulting in a market volume of US$15.28 million [21].

  • The anticipated profitability and decreasing controversy surrounding medical cannabis in Thailand are supported by the government's commitment to legalizing weed, which is expected to foster a more favorable market environment [22].

  • Market segmentation reveals a diverse range of cultivated species, derivatives, application areas, and end-use sectors, indicating a broadening scope for medical cannabis use and product development [23].

  • The hemp segment, particularly, has shown dominance with an 88.4% revenue share in 2021, largely due to its industrial applications, while the CBD segment claimed the largest revenue share at 68.4%, reflecting increased acceptance among consumers and the scientific community [15].

  • Key industry players are focusing on R&D to diversify product offerings and cater to varying patient needs, with companies like PharmaHemp, MediPharm Labs, Inc., and Cresco Labs leading the charge [15][23].

  • Government initiatives such as the "cannabis sandbox" for tourists and increasing CBD-related R&D activities are poised to further stimulate market growth [15].

  • Drawing from the USA's cannabis industry, Thailand can learn from the American market's focus on product innovation, differentiation, and the development of new business models, which have contributed to job creation, tax revenue growth, and investment in R&D [10].

  • The trend in the USA towards market consolidation offers Thailand insights into the potential need for economies of scale, competition, and regulatory compliance, as well as the importance of maintaining competitiveness among smaller businesses through proper regulation and encouragement of innovation [10].

  • Thailand's market growth is expected to benefit from the government's backing, favorable cultivation climate, and the country's rich tradition in herbal medicine, which could lead to increased usage and product diversity as more countries legalize medical cannabis and ease approval processes [21].

  • With healthcare expenditure in Thailand projected to reach USD 50 billion by 2026, the medical cannabis market is set to receive a substantial boost, complementing the country's economic and healthcare advancements [15].


What is Thailand's current stance on cannabis under the new government? The Thai government has announced plans to prohibit recreational cannabis use by the end of 2024. However, the country will maintain the legality of cannabis for medical purposes, as confirmed by the health minister.

Can cannabis be used for medical purposes in Thailand? Yes, medical use of cannabis is legal in Thailand. Despite previous criminalization under the Cannabis Act of 1935 and the Narcotics Act of 1979, Thailand legalized medical cannabis in 2018, becoming the first Asian country to do so.

What is the estimated size of Thailand's legal cannabis market? The legal cannabis market in Thailand was valued at approximately USD 80.3 million in 2021. It is projected to grow significantly, reaching an estimated USD 242.8 million in 2022.

Is the use of CBD permitted in Thailand? Yes, CBD (cannabidiol), which does not induce a psychoactive "high," is legal in Thailand. The legalization occurred in 2018 alongside the approval of marijuana for medical use and research, which aimed to enhance farm incomes. Following this change, companies invested heavily in the cannabis industry after the legalization of hemp and CBD.


[1] - [2] - [3] - [4] - [5] - [6] - [7] - [8] - [9] - [10] - [11] - [12] - [13] - [14] - [15] - [16] - [17] - [18] - [19] - [20] - [21] - [22] - [23] -

9 views0 comments


bottom of page